Published on in Vol 12 (2023)
![Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled Trial Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled Trial](https://asset.jmir.pub/assets/ca91cae7ca27fb571bbee051603c0842.png 480w,https://asset.jmir.pub/assets/ca91cae7ca27fb571bbee051603c0842.png 960w,https://asset.jmir.pub/assets/ca91cae7ca27fb571bbee051603c0842.png 1920w,https://asset.jmir.pub/assets/ca91cae7ca27fb571bbee051603c0842.png 2500w)
1 DREAM-CV Lab, McGill University Health Centre, McGill University, Montreal, QC, Canada
2 Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, McGill University, Montreal, QC, Canada
3 Division of Cardiology, McGill University Health Centre, McGill University, Montreal, QC, Canada
4 Division of Cardiology, University of Ottawa, Ottawa, ON, Canada
5 Montreal Heart Institute, University of Montreal, Montreal, QC, Canada
*these authors contributed equally